News Articles and Montana BioScience Alliance Newsletters
In recognition of her extraordinary contributions, Sharon has been inducted into the Montana Bioscience Hall of Fame, a fitting tribute to her enduring impact on our bioscience community. And to further honor her legacy, we are proud to announce the creation of the Sharon Peterson STEM Scholarship.
Device developed by Missoula company Gaize (gaize.ai) could help to keep people safe at work and on the road.
2M Beta is a 12-week program delivering the foundational and modern skills required to transform influential ideas into thriving businesses. With access to more professional expertise, more state-of-the-art technology and more community resources, C2M Beta was founded with the mission to connect local entrepreneurs to more!
A message from Board President Cynthia Tsai
SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company specializing in the discovery and development of innate immune modulators, announce an agreement in principle to create a strategic collaboration to develop and commercialize advanced adjuvant systems for vaccine development. This collaboration leverages Inimmune’s world-class expertise in adjuvant formulation and immunotherapeutics and SPI Pharma’s extensive manufacturing and global commercial capabilities.
Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.
Updates from product development and small business programs
The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the biotech industry, to fill the role of the organization’s new CEO.
Dec. 8 was a historic day for the sickle cell community and CRISPR technology, as the U.S. Food and Drug Administration (FDA) approved two milestone treatments: Casgevy, made by Vertex Pharmaceuticals, and Lyfgenia, made by bluebird bio.
The NIA is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2024, unless otherwise noted.
Members of the Montana BioScience Alliance are encouraged to explore the Montana Rural Health Initiative—a significant statewide investment focused on rural care delivery, workforce development, telehealth, and applied clinical innovation. This program offers Alliance companies and research partners a rare chance to access non-dilutive funding, pilot technologies in real clinical settings, and build direct partnerships with Montana healthcare systems and community stakeholders. Just as importantly, it creates a pathway to demonstrate impact while advancing commercialization inside Montana. Backed by the administration of Greg Gianforte, the initiative aligns […]
View the December BIOWire Newsletter now!